Company intelligence / Profile preview
Biovalys
- Ownership
- Private
- Employees
- ~120
- Development stage
- Other
Overview
Biovalys is a Thailand-based pharmaceutical company specializing in the development, importation, and distribution of vaccines and biopharmaceuticals. Founded in 2010, the company focuses on providing high-quality immunization solutions to address public health needs in Southeast Asia. Their portfolio includes vaccines for rabies, Japanese encephalitis, influenza, and various pediatric combination vaccines. Biovalys collaborates with international manufacturers to bring innovative biological products to the Thai market and ensures rigorous cold chain management for product integrity. The company plays a significant role in supporting the National Expanded Program on Immunization in Thailand.
- Therapeutic areas
- Infectious Diseases
- Modalities
- VaccineBiologic
- Industry
- Biotech
Drug pipeline
1 assetPartnerships
Beyond the preview
Go deeper on Biovalys.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Biovalys.